Long-Term Immunosuppressive Therapy for Dog Skin Disease: Monitoring and Safety

By Emiel Maddens · Reviewed in consultation with licensed veterinary professionals · Updated July 2026 · 9 min read

What Is Long-Term Immunosuppressive Therapy for Dog Skin Disease?

Long-term immunosuppressive therapy is the sustained use of medications that suppress or modulate the immune system to control chronic skin diseases in which the immune response attacks the skin or overreacts to allergens. Veterinarians reach for these drugs when a condition cannot be controlled by topical care alone, such as pemphigus foliaceus, cutaneous lupus, vasculitis, or severe refractory atopic dermatitis.

The most common agents include glucocorticoids (prednisone, prednisolone), the antimetabolite azathioprine, the calcineurin inhibitor cyclosporine (Atopica), mycophenolate mofetil, and, for atopic disease, the targeted agents oclacitinib and lokivetmab. Studies report that 60 to 90 percent of dogs with pemphigus foliaceus achieve remission on combination immunosuppression, but many require lifelong therapy at a maintenance dose. Because these medications reduce the body's ability to fight microbes, monitoring is not optional, it is what makes long-term treatment safe. For an overview of the diseases that require this approach, see our guide on managing autoimmune skin flares in dogs.

What Are the Main Risks of Long-Term Immunosuppression?

The central risk of chronic immunosuppression is increased susceptibility to infection, because the same immune activity that damages skin also defends against bacteria, yeast, and other pathogens. Secondary bacterial pyoderma and Malassezia (yeast) overgrowth affect an estimated 30 to 50 percent of dogs on long-term therapy, and these infections can mimic a disease flare, leading to unnecessary dose increases if not identified.

Drug-specific effects add further risk. Glucocorticoids can cause iatrogenic Cushing's signs, muscle wasting, urinary tract infections, and diabetes. Azathioprine carries a risk of bone marrow suppression and hepatotoxicity, with liver enzyme elevations reported in up to 15 percent of treated dogs. Cyclosporine may cause gingival overgrowth and gastrointestinal upset. This is why veterinarians track both the disease and the drug at every recheck, and why owners should watch for new lethargy, increased drinking, or a foul skin odor between visits.

How Do Veterinarians Monitor Dogs on Immunosuppressive Drugs?

Veterinarians monitor immunosuppressed dogs with a structured schedule of physical examinations, laboratory testing, and skin surveillance rather than waiting for problems to appear. A typical protocol includes a baseline complete blood count (CBC), serum chemistry panel, and urinalysis before starting, then repeat bloodwork at 2 to 4 week intervals during induction, followed by every 2 to 4 months once the dog is on a stable maintenance dose.

For azathioprine specifically, a CBC every 1 to 2 weeks for the first 8 weeks is standard to catch bone marrow suppression before it becomes dangerous. Urine cultures are often performed periodically because glucocorticoids can mask the signs of a urinary tract infection. Skin cytology at rechecks identifies secondary bacterial or yeast infection early, which directly informs whether an increase in itch or lesions reflects the underlying disease or a treatable infection. When owners are unsure whether new symptoms are a flare or an infection, our Dog Skin Condition Checker can help frame the conversation before a visit.

Signs and Symptoms to Watch For at Home

Between veterinary visits, owners are the first line of monitoring, and knowing which changes signal a drug side effect versus a secondary infection helps you act quickly. The table below compares common warning signs and what they may indicate.

How Do You Reduce Infection Risk During Treatment?

Reducing secondary infection risk is one of the most practical ways to keep a dog safe on long-term immunosuppression and often allows the veterinarian to use lower systemic drug doses. Because the skin barrier is compromised in most autoimmune and atopic diseases, controlling surface bacteria and yeast lowers the microbial load the weakened immune system has to manage.

Topical antimicrobial therapy is a cornerstone here. Chlorhexidine Spray contains 2 percent chlorhexidine gluconate, a broad-spectrum antiseptic that disrupts the cell membranes of Staphylococcus pseudintermedius and Malassezia yeast, the two organisms most often responsible for secondary skin infection in immunosuppressed dogs. Applied to focal lesions or fold areas, it targets microbes topically without adding to the systemic drug burden. Owners also benefit from reviewing how these infections take hold in vulnerable dogs, covered in our article on age-related immune decline and recurrent skin infections, and the broader treatment context in bacterial skin infections in dogs.

How Is Immunosuppressive Therapy Safely Tapered?

Immunosuppressive therapy is tapered gradually toward the lowest effective dose, never stopped abruptly, because sudden withdrawal can trigger a severe disease flare or, with glucocorticoids, a life-threatening Addisonian crisis from adrenal suppression. Veterinarians typically reduce the dose by 20 to 25 percent every 2 to 4 weeks while watching for the return of skin lesions.

Many dogs reach a maintenance dose given every other day or at a low daily amount, and some can eventually discontinue one drug in a combination protocol while staying on another. The goal is durable disease control with the fewest side effects, which is why tapering decisions rely on both clinical appearance and recheck cytology. Rushing the taper is a common cause of relapse, so patience and consistent monitoring pay off over the long term.

Prevention and Long-Term Management

Long-term success with immunosuppressive therapy depends on partnership between owner and veterinarian, consistent monitoring, and proactive skin care rather than reacting only when a crisis appears. Keeping a simple home log of appetite, thirst, energy, and skin condition gives your veterinarian valuable trend data at each recheck.

Maintaining every scheduled bloodwork appointment is the single most important preventive step, because it catches organ effects before they cause symptoms. Supporting the skin barrier with gentle bathing, topical antimicrobial care between infections, and prompt attention to any new lesion reduces the frequency of flares and the doses required to control them. Dogs on stable, well-monitored protocols frequently live full, comfortable lives, and many maintain remission for years with careful management.

Frequently Asked Questions

How often does my dog need bloodwork on immunosuppressive drugs?

Most protocols call for baseline bloodwork before starting, frequent testing every 1 to 4 weeks during the induction phase, then a CBC and chemistry panel every 2 to 4 months once your dog is on a stable maintenance dose. Azathioprine requires more frequent early monitoring, often a CBC every 1 to 2 weeks for the first 8 weeks.

Can immunosuppressive therapy for skin disease be stopped once the skin clears?

Usually not abruptly. Many autoimmune skin diseases require lifelong maintenance therapy at the lowest effective dose. Even when discontinuation is possible, it is done through a gradual taper over weeks to months to avoid a disease flare or, with steroids, an Addisonian crisis.

Why does my immunosuppressed dog keep getting skin infections?

The medications that control the autoimmune or allergic disease also reduce the immune system's ability to fight bacteria and yeast. An estimated 30 to 50 percent of dogs on long-term immunosuppression develop secondary infections. Topical antimicrobial care and regular skin cytology help catch and control these early.

What are the warning signs of a serious drug side effect?

Seek urgent veterinary care for pale gums, weakness, or bruising (possible bone marrow suppression), vomiting with yellow gums or poor appetite (possible liver toxicity), or sudden collapse and severe lethargy in a dog tapering off steroids (possible Addisonian crisis).

Does topical treatment reduce the amount of systemic medication my dog needs?

It can help. By lowering the load of surface bacteria and yeast that a weakened immune system must manage, consistent topical antimicrobial care reduces the frequency and severity of secondary infections, which sometimes allows veterinarians to maintain control at a lower systemic dose.

Sources

1. Miller WH, Griffin CE, Campbell KL. Muller and Kirk's Small Animal Dermatology. Elsevier. 2013;7th ed:432-500.
2. Olivry T, Bergvall KE. Toxicity and monitoring of immunosuppressive therapy in canine dermatoses. Veterinary Dermatology. 2014;25(2):89-97.
3. Gregory CR. Immunosuppressive agents in small animal medicine. JAVMA. 2000;216(9):1435-1441.
4. Whitley NT, Day MJ. Immunomodulatory drugs and their application to the management of canine immune-mediated disease. Journal of Small Animal Practice. 2011;52(2):70-85.

Related Reading

• Managing Autoimmune Skin Flares in Dogs: Prevention and Emergency Care
• Age-Related Immune Decline and Recurrent Skin Infections in Senior Dogs
• Medication Interactions in Senior Dogs: Safe Skin Treatment Combinations

Emiel Maddens

Founder of Vetified. Develops topical antifungal and antimicrobial formulations for companion animals. Vetified products are listed on DailyMed and manufactured through FDA-registered facilities in the United States.

Veterinary review: All Vetified content is developed in consultation with licensed veterinary professionals and references peer-reviewed research published in journals including Veterinary Dermatology, JAVMA, and Journal of Small Animal Practice.